Citations

Clear

513 citation(s) found for "Ta, Casey".

Ascending the learning curve – MSI testing experience of a six-laboratory consortium
Lindor, Noralane M. , Smalley, Regenia L., Barker, Melissa, Bigler, Jeannette, Krumroy, Lisa M., Lum‐Jones, Annette, Plummer, Sarah J. , Selander, Teresa, Thomas, Sushma , Youash, Michelle, Seminara, Daniela, Bapat, Bharati , Thibodeau, Stephen N. , Casey, Graham

Mayo Clinic

Cancer Biomarkers | January 31, 2017 | Volume: 2 | Issue: 1-2 | Pages: 5-9

10.3233/cbm-2006-21-202 | PMID 17192055 Get It

A novel Rab10-EHBP1-EHD2 complex essential for the autophagic engulfment of lipid droplets
Li, Zhipeng , Schulze, Ryan J. , Weller, Shaun G. , Krueger, Eugene W. , Liu, Jun , Stöckli, Jacqueline, James, David E. , McNiven, Mark A. , Schott, Micah B. , Liu, Jun , Stöckli, Jacqueline , James, David E , Zhang, Xiaodong , Casey, Carol A.

Mayo Clinic

Science Advances | December 17, 2016 | Volume: 2 | Issue: 12 | Pages: No page available

10.1126/sciadv.1601470 | PMID 28028537 Get It

A novel protein complex facilitates lipid droplet autophagy.
Influence of sympathetic nerve activity on aortic hemodynamics and pulse wave velocity in women
Harvey, Ronée E. , Barnes, Jill N. , Hart, Emma C. , Nicholson, Wayne T. , Joyner, Michael J. , Casey, Darren P. , Barnes, J N , Harvey, Ronée E , Joyner, Michael J , Hart, Emma C

Mayo Clinic

American Journal of Physiology-Heart and Circulatory Physiology | December 7, 2016 | Volume: 312 | Issue: 2 | Pages: H340-H346

10.1152/ajpheart.00447.2016 | PMID 27923789 Get It

Central (aortic) blood pressure, arterial stiffness, and sympathetic nerve activity increase with age in women. However, it is unknown if the age-related increase in sympathetic activity influences aortic hemodynamics and carotid-femoral pulse wave velocity (cfPWV), an index of central aortic stiffness. The goal of this study was to determine if aortic hemodynamics and cfPWV are directly influenced by sympathetic nerve activity by measuring aortic hemodynamics, cfPWV, and muscle sympathetic nerve activity (MSNA) in women before and during autonomic ganglionic blockade with trimethaphan camsylate. We studied 12 young premenopausal (23 ± 4 yr) and 12 older postmenopausal (57 ± 3 yr) women. These women did not differ in body mass index or mean arterial pressure ( P > 0.05 for both). At baseline, postmenopausal women had higher aortic pulse pressure, augmented pressure, augmentation index adjusted for a heart rate of 75 beats/min, wasted left ventricular pressure energy, and cfPWV than young women ( P < 0.05). During ganglionic blockade, postmenopausal women had a greater decrease in these variables in comparison to young women ( P < 0.05). Additionally, baseline MSNA was negatively correlated with the reductions in aortic pulse pressure, augmented pressure, and wasted left ventricular pressure energy during ganglionic blockade in postmenopausal women ( P < 0.05) but not young women. Baseline MSNA was not correlated with the changes in augmentation index adjusted for a heart rate of 75 beats/min or cfPWV in either group ( P > 0.05 for all). Our results suggest that some aortic hemodynamic parameters are influenced by sympathetic activity to a greater extent in older postmenopausal women than in young premenopausal women.NEW & NOTEWORTHY Autonomic ganglionic blockade results in significant decreases in multiple aortic pulse wave characteristics (e.g., augmented pressure) and central pulse wave velocity in older postmenopausal women but not in young premenopausal women. Certain aortic pulse wave parameters are negatively influenced by sympathetic activity to a greater extent in older postmenopausal women.
Oral Progestogens Versus Levonorgestrel-Releasing Intrauterine System for Treatment of Endometrial Intraepithelial Neoplasia
Marnach, Mary L. , Butler, Kristina , Henry, Michael , Hutz, Catherine E., Lohse, Christine M. , Casey, Petra M., Butler, Kristina A., Henry, Michael R, Langstraat, Carrie

Mayo Clinic

Journal of Women's Health | November 30, 2016 | Volume: 26 | Issue: 4 | Pages: 368-373

10.1089/jwh.2016.5774 | PMID 27901412 Get It

Drospirenone Litigation: Does the Punishment Fit the Crime?
Batur, Pelin , Casey, Petra M.

Mayo Clinic

Journal of Women's Health | November 17, 2016 | Volume: 26 | Issue: 2 | Pages: 99-102

10.1089/jwh.2016.6092 | PMID 27854556 Get It

Alcohol Consumption and the Risk of Colorectal Cancer for Mismatch Repair Gene Mutation Carriers
Dashti, S. Ghazaleh , Buchanan, Daniel D. , Jayasekara, Harindra , Ouakrim, Driss Ait , Rosty, Christophe , Winship, Ingrid , Parry, Susan, Haile, Robert W. , Gallinger, Steven , Thibodeau, Stephen N. , Lindor, Noralane M. , Jenkins, Mark A. , Win, Aung Ko , Clendenning, Mark , Macrae, Finlay , Giles, Graham G. , Casey, Graham , Marchand, Loı̈c Le , Newcomb, Polly A. , Potter, John D. , Baron, John A. , Hopper, John L. , Buchanan, Daniel D , Win, Aung K , Jenkins, Mark A , Haile, Robert W , Rosty, Christophe , Winship, Ingrid M , Jayasekara, Harindra

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | November 4, 2016 | Volume: 26 | Issue: 3 | Pages: 366-375

10.1158/1055-9965.epi-16-0496 | PMID 27811119 Get It

Abstract Background: People with germline mutation in one of the DNA mismatch repair (MMR) genes have increased colorectal cancer risk. For these high-risk people, study findings of the relationship between alcohol consumption and colorectal cancer risk have been inconclusive. Methods: 1,925 MMR gene mutations carriers recruited into the Colon Cancer Family Registry who had completed a questionnaire on lifestyle factors were included. Weighted Cox proportional hazard regression models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for the association between alcohol consumption and colorectal cancer. Results: Colorectal cancer was diagnosed in 769 carriers (40%) at a mean (SD) age of 42.6 (10.3) years. Compared with abstention, ethanol consumption from any alcoholic beverage up to 14 g/day and &gt;28 g/day was associated with increased colorectal cancer risk (HR, 1.50; 95% CI, 1.09–2.07 and 1.69; 95% CI, 1.07–2.65, respectively; Ptrend = 0.05), and colon cancer risk (HR, 1.78; 95% CI, 1.27–2.49 and 1.94; 95% CI, 1.19–3.18, respectively; Ptrend = 0.02). However, there was no clear evidence for an association with rectal cancer risk. Also, there was no evidence for associations between consumption of individual alcoholic beverage types (beer, wine, spirits) and colorectal, colon, or rectal cancer risk. Conclusions: Our data suggest that alcohol consumption, particularly more than 28 g/day of ethanol (∼2 standard drinks of alcohol in the United States), is associated with increased colorectal cancer risk for MMR gene mutation carriers. Impact: Although these data suggested that alcohol consumption in MMR carriers was associated with increased colorectal cancer risk, there was no evidence of a dose-response, and not all types of alcohol consumption were associated with increased risk. Cancer Epidemiol Biomarkers Prev; 26(3); 366–75. ©2016 AACR.
Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer
Win, Aung Ko , Jenkins, Mark A. , Antoniou, Antonis C. , Buchanan, Daniel D. , Rosty, Christophe , Ahnen, Dennis J. , Thibodeau, Stephen N. , Gallinger, Steven , Haile, Robert W., Zheng, Yingye , Lindor, Noralane M. , MacInnis, Robert J. , Haile, Robert W. , Dowty, James G. , Lee, Andrew , Giles, Graham G. , Clendenning, Mark , Casey, Graham , Marchand, Loı̈c Le , Potter, John D. , Zheng, Yingye , Newcomb, Polly A. , Hopper, John L. , Buchanan, Daniel D , Win, Aung K , Jenkins, Mark A , Haile, Robert W , Maclnnis, Robert , Rosty, Christophe

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | October 31, 2016 | Volume: 26 | Issue: 3 | Pages: 404-412

10.1158/1055-9965.epi-16-0693 | PMID 27799157 Get It

Abstract Background: Although high-risk mutations in identified major susceptibility genes (DNA mismatch repair genes and MUTYH) account for some familial aggregation of colorectal cancer, their population prevalence and the causes of the remaining familial aggregation are not known. Methods: We studied the families of 5,744 colorectal cancer cases (probands) recruited from population cancer registries in the United States, Canada, and Australia and screened probands for mutations in mismatch repair genes and MUTYH. We conducted modified segregation analyses using the cancer history of first-degree relatives, conditional on the proband's age at diagnosis. We estimated the prevalence of mutations in the identified genes, the prevalence of HR for unidentified major gene mutations, and the variance of the residual polygenic component. Results: We estimated that 1 in 279 of the population carry mutations in mismatch repair genes (MLH1 = 1 in 1,946, MSH2 = 1 in 2,841, MSH6 = 1 in 758, PMS2 = 1 in 714), 1 in 45 carry mutations in MUTYH, and 1 in 504 carry mutations associated with an average 31-fold increased risk of colorectal cancer in unidentified major genes. The estimated polygenic variance was reduced by 30% to 50% after allowing for unidentified major genes and decreased from 3.3 for age &lt;40 years to 0.5 for age ≥70 years (equivalent to sibling relative risks of 5.1 to 1.3, respectively). Conclusions: Unidentified major genes might explain one third to one half of the missing heritability of colorectal cancer. Impact: Our findings could aid gene discovery and development of better colorectal cancer risk prediction models. Cancer Epidemiol Biomarkers Prev; 26(3); 404–12. ©2016 AACR.
Comprehensive Cross-Population Analysis of High-Grade Serous Ovarian Cancer Supports No More Than Three Subtypes
Way, Gregory P. , Rudd, James , Hamidi, Habib , Konecny, Gottfried E. , Goode, Ellen L. , Greene, Casey S. , Doherty, Jennifer A. , Greene, Casey S , Doherty, Jennifer A , Wang, Chen , Fridley, Brooke L.

Mayo Clinic

G3 Genes|Genomes|Genetics | October 24, 2016 | Volume: 6 | Issue: 12 | Pages: 4097-4103

10.1534/g3.116.033514 | PMID 27729437 Get It

Abstract Four gene expression subtypes of high-grade serous ovarian cancer (HGSC) have been previously described. In these early studies, a fraction of samples that did not fit well into the four subtype classifications were excluded. Therefore, we sought to systematically determine the concordance of transcriptomic HGSC subtypes across populations without removing any samples. We created a bioinformatics pipeline to independently cluster the five largest mRNA expression datasets using k-means and nonnegative matrix factorization (NMF). We summarized differential expression patterns to compare clusters across studies. While previous studies reported four subtypes, our cross-population comparison does not support four. Because these results contrast with previous reports, we attempted to reproduce analyses performed in those studies. Our results suggest that early results favoring four subtypes may have been driven by the inclusion of serous borderline tumors. In summary, our analysis suggests that either two or three, but not four, gene expression subtypes are most consistent across datasets.
IC‐01‐05: Neuropathologic Features of AV1451 TAU Pet Autoradiography in Dementia
Curran, Geoffry L., Fang, Ping , Josephs, Keith A. , Parisi, Joseph E., Bruinsma, Tyler J. , Petrucelli, Leonard , Cook, Casey , Petersen, Ronald C. , Lowe, Val J. , Murray, Melissa E. , Kantarci, Kejal , Boeve, Bradley F. , Pandey, Mukesh K. , Knopman, David S. , Jones, David T. , Dickson, Dennis W. , Jack, Clifford R.

Mayo Clinic

Alzheimer's & Dementia | October 17, 2016 | Volume: 12 | Issue: 7S_Part_1 | Pages: No page available

10.1016/j.jalz.2016.06.065 Get It

The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers
Wang, Zhaoming , Schumacher, Fredrick R. , Gayther, Simon A. , Casey, Graham , Sellers, Thomas A. , Gruber, Stephen B., Dunning, Alison M. , Michailidou, Kyriaki , Fachal, Laura , Doheny, Kimberly F. , Li, Yafang , Xiao, Xiangjun , Romm, Jane, Pugh, Elizabeth, Coetzee, Gerhard A. , Hazelett, Dennis J. , Bojesen, Stig E. , Caga-Anan, Charlisse , Haiman, Christopher A. , Kamal, Ahsan , Luccarini, Craig , Tessier, Daniel C., Vincent, Daniel , Bacot, François, Berg, David Van Den , Nelson, Stefanie A. , Demetriades, Stephen, Goldgar, David E., Forman, Judith L., Conti, David V. , Bickeböller, Heike , Risch, Angela , Waldenberger, Mélanie , Brüske‐Hohlfeld, Irene, Hicks, Belynda , McGuffog, Lesley, Kuchenbaecker, Karoline , Soucy, Penny, Manz, Judith, Cunningham, Julie M. , Butterbach, Katja, Kote‐Jarai, Zsofia , Kraft, Peter , Lindström, Sara , Adams, Marcia, McKay, James , Phelan, Catherine M., Benlloch, Sara, Kelemen, Linda E., Brennan, Paul , Riggan, Marjorie J. , O’Mara, Tracy A. , Shen, Hongbing , Shi, Yongyong , Thompson, Deborah J. , Goodman, Marc T. , Nielsen, Sune F. , LaBoissière, Sylvie, Schmit, Stephanie L. , Shelford, Tameka, Edlund, Christopher K., Taylor, Jack A. , Field, John K. , Park, Sue K. , Offit, Kenneth , Thomassen, Mads , Schmutzler, Rita K., Ottini, Laura , Hung, Rayjean J., Olama, Ali Amin Al , Peters, Ulrike , Eeles, Rosalind A. , Seldin, Michael F., Gillanders, Elizabeth M. , Seminara, Daniela, Antoniou, Antonis C. , Chenevix‐Trench, Georgia , Simard, Jacques , Easton, Douglas F. , Durocher, Francine , Hung, Rayjean J. , Amos, Christopher I. , Dennis, Joe , Byun, Jinyoung , Hunter, David J. , Spurdle, Amanda B. , Couch, Fergus J. , Giles, Graham G. , Ling, Hua , Lee, Andrew , FitzGerald, Liesel M. , Berchuck, Andrew , Marchini, Jonathan , Pharoah, Paul D.P. , Chanock, Stephen Jacob , Hazelett, Dennis J , Eeles, Rosalind A , Van Den Berg, David J , Hung, Rayjean J , Wang, Zhaoming , O'Mara, Tracy A , Field, John K , Dunning, Alison M , Michailidou, Kyriaki , Taylor, Jack A , Kraft, Peter , Simard, Jacques , Chenevix-Trench, Georgia , Ottini, Laura , Conti, David V , Bojesen, Stig E , Risch, Angela , Bickeböller, Heike , Shen, Hongbing , Goodman, Marc T , Fachal, Laura

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | October 3, 2016 | Volume: 26 | Issue: 1 | Pages: 126-135

10.1158/1055-9965.epi-16-0106 | PMID 27697780 Get It

Abstract Background: Common cancers develop through a multistep process often including inherited susceptibility. Collaboration among multiple institutions, and funding from multiple sources, has allowed the development of an inexpensive genotyping microarray, the OncoArray. The array includes a genome-wide backbone, comprising 230,000 SNPs tagging most common genetic variants, together with dense mapping of known susceptibility regions, rare variants from sequencing experiments, pharmacogenetic markers, and cancer-related traits. Methods: The OncoArray can be genotyped using a novel technology developed by Illumina to facilitate efficient genotyping. The consortium developed standard approaches for selecting SNPs for study, for quality control of markers, and for ancestry analysis. The array was genotyped at selected sites and with prespecified replicate samples to permit evaluation of genotyping accuracy among centers and by ethnic background. Results: The OncoArray consortium genotyped 447,705 samples. A total of 494,763 SNPs passed quality control steps with a sample success rate of 97% of the samples. Participating sites performed ancestry analysis using a common set of markers and a scoring algorithm based on principal components analysis. Conclusions: Results from these analyses will enable researchers to identify new susceptibility loci, perform fine-mapping of new or known loci associated with either single or multiple cancers, assess the degree of overlap in cancer causation and pleiotropic effects of loci that have been identified for disease-specific risk, and jointly model genetic, environmental, and lifestyle-related exposures. Impact: Ongoing analyses will shed light on etiology and risk assessment for many types of cancer. Cancer Epidemiol Biomarkers Prev; 26(1); 126–35. ©2016 AACR.